BE616646A
(ja)
|
|
|
|
|
DE1124485B
(de)
|
1960-02-12 |
1962-03-01 |
Hoechst Ag |
Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
|
US3496181A
(en)
*
|
1966-10-24 |
1970-02-17 |
Upjohn Co |
2 - aminocycloalkyl hydroquinones,esters,ethers and n-oxides thereof,and a process for preparing the same
|
GB1207731A
(en)
*
|
1968-05-14 |
1970-10-07 |
Reckitt & Sons Ltd |
Derivatives of pyrrolidine
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US3974157A
(en)
*
|
1974-03-04 |
1976-08-10 |
Pennwalt Corporation |
1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4287212A
(en)
*
|
1976-04-30 |
1981-09-01 |
American Hoechst Corporation |
2-Aryl-1,2-dialkylcycloalkylamines
|
JPS6033106B2
(ja)
|
1977-10-07 |
1985-08-01 |
住友化学工業株式会社 |
カルボン酸エステル、その製造法およびそれを有効成分とする殺虫、殺ダニ剤
|
ZA817261B
(en)
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
KR840002817A
(ko)
*
|
1982-02-09 |
1984-07-21 |
케네스 엠 사이러스 |
2-(페닐메틸렌)사이클로알킬아민 및 -아제티딘화합물의 제조방법
|
US4540690A
(en)
*
|
1982-02-09 |
1985-09-10 |
The Upjohn Company |
2-(Phenylmethylene)cycloalkylamines and -azetidines
|
JPS58177915A
(ja)
|
1982-04-12 |
1983-10-18 |
Green Cross Corp:The |
抗血栓剤
|
EP0152032B1
(en)
|
1984-02-03 |
1988-10-26 |
Olympus Optical Co., Ltd. |
Calculus crushing apparatus
|
JPS60172970A
(ja)
*
|
1984-02-15 |
1985-09-06 |
Shionogi & Co Ltd |
シス−アゾリルシクロアルカノ−ル誘導体およびその製造法ならびに農業用殺菌剤
|
CA1244041A
(en)
|
1984-07-30 |
1988-11-01 |
Elijah H. Gold |
Process for the preparation of cis, endo- octahydrocyclopenta¬b|pyrrole-2-carboxylate
|
DE3431541A1
(de)
|
1984-08-28 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US4738709A
(en)
|
1985-01-10 |
1988-04-19 |
Ppg Industries, Inc. |
Herbicidally active substituted benzisoxazoles
|
US4751231A
(en)
|
1987-09-16 |
1988-06-14 |
Merck & Co., Inc. |
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
|
JPH01172388A
(ja)
|
1987-12-25 |
1989-07-07 |
Sumitomo Chem Co Ltd |
チエノ〔3,2−b〕ピロロ〔2,3−d〕ピロール類およびその製法
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
JPH0347123A
(ja)
|
1989-05-05 |
1991-02-28 |
G D Searle & Co |
インドール―2―カルボキシレート化合物類を含有するcns疾患治療用組成物
|
AU654653B2
(en)
|
1989-05-31 |
1994-11-17 |
Pharmacia & Upjohn Company |
Therapeutically useful 2-aminotetralin derivatives
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
ATE126511T1
(de)
|
1990-02-02 |
1995-09-15 |
Schering Corp |
4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung.
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
JPH0477476A
(ja)
|
1990-07-19 |
1992-03-11 |
Sankyo Co Ltd |
抗潰瘍剤
|
US5086054A
(en)
|
1990-07-31 |
1992-02-04 |
Sri International |
Novel arylcycloalkanepolyalkylamines
|
JP3007138B2
(ja)
|
1990-11-27 |
2000-02-07 |
ファイザー製薬株式会社 |
新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
GB9208492D0
(en)
|
1992-04-16 |
1992-06-03 |
Glaxo Spa |
Heterocyclic compounds
|
JP3457669B2
(ja)
|
1992-10-28 |
2003-10-20 |
富山化学工業株式会社 |
新規な1,2−ベンゾイソオキサゾール誘導体またはその塩,それらからなる脳保護剤
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
GB9304500D0
(en)
|
1993-03-05 |
1993-04-21 |
Glaxo Spa |
Heterocyclic compounds
|
ES2081747B1
(es)
|
1993-09-07 |
1997-01-16 |
Esteve Labor Dr |
Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
|
GB9321221D0
(en)
|
1993-10-14 |
1993-12-01 |
Glaxo Spa |
Heterocyclic compounds
|
GB9326284D0
(en)
|
1993-12-23 |
1994-02-23 |
Erba Carlo Spa |
Pyrrolydenemethyl-derivatives and process for their preparation
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
CN1047384C
(zh)
|
1994-07-28 |
1999-12-15 |
北京大学 |
雷米普利的合成方法
|
ES2208690T3
(es)
|
1994-08-30 |
2004-06-16 |
Sankyo Company Limited |
Isoxazol.
|
US5484763A
(en)
|
1995-02-10 |
1996-01-16 |
American Cyanamid Company |
Substituted benzisoxazole and benzisothiazole herbicidal agents
|
US5620997A
(en)
|
1995-05-31 |
1997-04-15 |
Warner-Lambert Company |
Isothiazolones
|
US5859042A
(en)
|
1995-09-27 |
1999-01-12 |
Ono Pharmaceutical Co., Ltd. |
Five membered heterocyclic compounds
|
ATE239694T1
(de)
|
1995-10-26 |
2003-05-15 |
Mitsubishi Pharma Corp |
Phenylethanolamin-verbindungen und ihre anwendung als beta3 agonisten, verfahren zu ihrer herstellung und zwischenprodukte ihrer herstellung
|
DE59709437D1
(de)
*
|
1996-01-31 |
2003-04-10 |
Altana Pharma Ag |
Neue phenanthridine
|
DE19711785A1
(de)
|
1997-03-21 |
1998-09-24 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
US6503582B1
(en)
|
1997-08-19 |
2003-01-07 |
Mattel, Inc. |
Fluid-swellable composition, device and method for using the same
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
AU9275498A
(en)
|
1997-10-03 |
1999-04-27 |
Chirotech Technology Limited |
Chiral amines
|
GB9803228D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
GB9803226D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
WO1999048868A2
(en)
|
1998-03-26 |
1999-09-30 |
Sugen, Inc. |
Heterocyclic classes of compounds for the modulating tyrosine protein kinase
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
IL142778A0
(en)
*
|
1998-12-02 |
2002-03-10 |
Darwin Discovery Ltd |
Therapeutic product and its use
|
US6828460B2
(en)
*
|
1999-03-22 |
2004-12-07 |
Pfizer Inc. |
Resorcinol derivatives
|
DE19915601A1
(de)
*
|
1999-04-07 |
2000-10-19 |
Gruenenthal Gmbh |
3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
|
FR2795733B1
(fr)
|
1999-06-30 |
2001-09-07 |
Aventis Pharma Sa |
Derives de streptogramines, leur preparation et les compositions qui les contiennent
|
EP1088824B1
(en)
|
1999-09-30 |
2004-01-07 |
Pfizer Products Inc. |
Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
EP1391460A1
(en)
|
1999-09-30 |
2004-02-25 |
Pfizer Products Inc. |
Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
ATE285821T1
(de)
|
1999-10-08 |
2005-01-15 |
Affinium Pharm Inc |
Fab i inhibitoren
|
WO2001042203A1
(en)
*
|
1999-12-08 |
2001-06-14 |
Eli Lilly And Company |
Cyclopentyl sulfonamide derivatives
|
DE19960917A1
(de)
|
1999-12-17 |
2001-06-21 |
Bayer Ag |
Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen
|
DE10000312A1
(de)
|
2000-01-05 |
2001-07-12 |
Gruenenthal Gmbh |
Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
|
US6632417B2
(en)
|
2000-03-07 |
2003-10-14 |
Chevron U.S.A. Inc. |
Process for preparing zeolites
|
JP2001247462A
(ja)
|
2000-03-07 |
2001-09-11 |
Otsuka Pharmaceut Co Ltd |
ウレアーゼ阻害剤
|
EP1136071A3
(en)
|
2000-03-22 |
2003-03-26 |
Pfizer Products Inc. |
Use of glycogen phosphorylase inhibitors
|
US6632948B2
(en)
|
2000-04-19 |
2003-10-14 |
Kaneka Corporation |
Azetidine derivative and process for preparation thereof
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
AU2001280461A1
(en)
|
2000-08-04 |
2002-02-18 |
Eli Lilly And Company |
Substituted pyrrole compounds and their use as spla2 inhibitors
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
DE10049481A1
(de)
*
|
2000-09-29 |
2002-05-02 |
Gruenenthal Gmbh |
Substituierte C-Cyclohexylmethylamin-Derivate
|
DE10049483A1
(de)
*
|
2000-09-29 |
2002-05-02 |
Gruenenthal Gmbh |
Substituierte 1-Aminobutan-3-ol-Derivate
|
CA2424987A1
(en)
|
2000-10-06 |
2002-04-18 |
Smithkline Beecham Corporation |
Methods of agonizing and antagonizing fabk
|
AU2002212959A1
(en)
*
|
2000-10-13 |
2002-04-29 |
Eli Lilly And Company |
Cycloalkylfluorosulfonamide derivatives
|
SE0003810D0
(sv)
|
2000-10-20 |
2000-10-20 |
Pharmacia Ab |
Novel compounds their use and preparations
|
TWI283575B
(en)
|
2000-10-31 |
2007-07-11 |
Eisai Co Ltd |
Medicinal compositions for concomitant use as anticancer agent
|
DE10063992A1
(de)
|
2000-12-21 |
2002-07-04 |
Max Planck Gesellschaft |
Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen
|
US6372919B1
(en)
|
2001-01-11 |
2002-04-16 |
Dov Pharmaceutical, Inc. |
(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
|
US20020123490A1
(en)
|
2001-03-01 |
2002-09-05 |
Pfizer Inc. |
Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
|
US7365205B2
(en)
|
2001-06-20 |
2008-04-29 |
Daiichi Sankyo Company, Limited |
Diamine derivatives
|
GB0115602D0
(en)
|
2001-06-26 |
2001-08-15 |
Syngenta Participations Ag |
Organic compounds
|
DE10132747A1
(de)
*
|
2001-07-05 |
2003-01-23 |
Gruenenthal Gmbh |
Substituierte 1-Aryl-but-3-enylamin- und 1-Aryl-but-2-enylaminverbindungen
|
US6603000B2
(en)
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
BR0211565A
(pt)
|
2001-08-09 |
2004-06-29 |
Daiichi Seiyaku Co |
Derivados de diamina
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
US20030162825A1
(en)
|
2001-11-09 |
2003-08-28 |
Sepracor Inc. |
D-amino acid oxidase inhibitors for learning and memory
|
WO2003048113A1
(en)
|
2001-11-30 |
2003-06-12 |
Sepracor Inc. |
Tramadol analogs and uses thereof
|
DE10164581A1
(de)
*
|
2001-12-14 |
2003-06-26 |
Gruenenthal Gmbh |
Substituierte Aminoalkohole
|
DE10161809A1
(de)
|
2001-12-14 |
2003-06-26 |
Gruenenthal Gmbh |
Arzneimittel enthaltend N,N'-disubstituierte Piperazin-Verbindungen
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
US20030158078A1
(en)
*
|
2002-02-11 |
2003-08-21 |
Jeanne Chang |
Detergent composition comprising a block copolymer
|
GB0205170D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
JPWO2003091213A1
(ja)
|
2002-04-25 |
2005-09-02 |
アステラス製薬株式会社 |
新規なアミド誘導体又はその塩
|
WO2003092670A1
(en)
|
2002-05-03 |
2003-11-13 |
Warner-Lambert Company Llc |
Bombesin antagonists
|
FR2841487B1
(fr)
|
2002-06-26 |
2004-08-20 |
Solystic |
Procede de detection de plis simples et de plis en prise multiple dans une installation de tri postal
|
US20050182131A1
(en)
*
|
2002-07-19 |
2005-08-18 |
Gruenenthal Gmbh |
1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
|
DE10233048A1
(de)
*
|
2002-07-19 |
2004-01-29 |
Grünenthal GmbH |
Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
|
AU2003252299A1
(en)
|
2002-07-31 |
2004-02-16 |
Eisai Co., Ltd. |
Novel physiologically active substance
|
US7537891B2
(en)
|
2002-08-27 |
2009-05-26 |
Bristol-Myers Squibb Company |
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
|
DE60305052T2
(de)
|
2002-09-06 |
2006-12-21 |
Janssen Pharmaceutica N.V. |
Thienopyrrolyl und furanopyrrolyl verbindungen und deren verwendung als histamin h4 rezeptor liganden
|
JP4610336B2
(ja)
|
2002-09-16 |
2011-01-12 |
セプラコール インク. |
トランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミン及びそのホルムアミドによる中枢神経系障害の治療
|
US20040087661A1
(en)
|
2002-09-16 |
2004-05-06 |
Sepracor, Inc. |
Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
|
TW200418838A
(en)
*
|
2002-09-18 |
2004-10-01 |
Bristol Myers Squibb Co |
Compounds for the treatment of premature ejaculation
|
MXPA05003550A
(es)
|
2002-10-03 |
2006-01-24 |
Cypress Bioscience Inc |
Incremento de dosificacion y dosis diaria dividida de anti-depresivos para tratar padecimientos neurologicos.
|
GB0222909D0
(en)
|
2002-10-03 |
2002-11-13 |
Astrazeneca Ab |
Novel process and intermediates
|
GB0222912D0
(en)
|
2002-10-03 |
2002-11-13 |
Astrazeneca Ab |
Novel process and intermediates
|
US20040097554A1
(en)
|
2002-10-30 |
2004-05-20 |
Pfizer Inc |
Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
|
AU2003274462A1
(en)
|
2002-11-07 |
2004-06-07 |
Pfizer Products Inc. |
N-(indole-2-carbonyl) amides as anti-diabetic agents
|
CN100434420C
(zh)
|
2003-01-31 |
2008-11-19 |
株式会社三和化学研究所 |
阻碍二肽基肽酶ⅳ的化合物
|
WO2004089470A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
New amide derivatives and pharmaceutical use thereof
|
EP1633709A1
(en)
|
2003-04-30 |
2006-03-15 |
Pfizer Products Inc. |
Anti-diabetic agents
|
WO2004113345A1
(ja)
|
2003-06-20 |
2004-12-29 |
Japan Tobacco Inc. |
縮合ピロール化合物及びその医薬用途
|
PT1362864E
(pt)
|
2003-06-30 |
2007-07-23 |
Servier Lab |
Novo processo de síntese do perindopril e dos seus sais aceitáveis do ponto de vista farmacêutico
|
AU2004255863A1
(en)
|
2003-07-07 |
2005-01-20 |
Ciba Specialty Chemicals Holding Inc. |
Process for the preparation of furopyrroles
|
KR20130081319A
(ko)
|
2003-07-29 |
2013-07-16 |
시그너쳐 알 앤드 디 홀딩스, 엘엘씨 |
아미노산 프로드럭
|
GB0318463D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
GB0319759D0
(en)
|
2003-08-22 |
2003-09-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2005020986A1
(en)
|
2003-08-29 |
2005-03-10 |
Astrazeneca Ab |
Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
|
GB0320422D0
(en)
|
2003-08-30 |
2003-10-01 |
Astrazeneca Ab |
Chemical compounds
|
ES2297502T3
(es)
|
2003-10-23 |
2008-05-01 |
F. Hoffmann-La Roche Ag |
Derivados de triaza-espiropiperidinas para uso como inhibidores de glyt-1 en el tratamiento de trastornos neurologicos y neuropsiquiatricos.
|
US7396940B2
(en)
|
2003-10-23 |
2008-07-08 |
Hoffmann-La Roche Inc. |
Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
|
SI1420028T1
(sl)
|
2003-11-19 |
2007-06-30 |
Servier Lab |
Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
|
KR20060128978A
(ko)
|
2003-12-29 |
2006-12-14 |
세프라코 아이엔시. |
벤조[디]이속사졸3올 디에이에이오 억제제
|
RU2361862C2
(ru)
|
2003-12-29 |
2009-07-20 |
Сепракор Инк. |
Пиррольные и пиразольные ингибиторы daao
|
CA2559105A1
(en)
|
2004-03-16 |
2005-09-29 |
Janssen Pharmaceutica N.V. |
Benzisoxazoles
|
ATE472540T1
(de)
|
2004-05-07 |
2010-07-15 |
Warner Lambert Co |
Als h3-liganden geeignete 3- oder 4- monosubstituierte phenol- und thiophenol-derivate
|
MXPA06013270A
(es)
*
|
2004-05-14 |
2007-04-23 |
Johnson & Johnson |
Compuestos de opioide carboxamido.
|
CN1956975A
(zh)
*
|
2004-05-21 |
2007-05-02 |
默克公司 |
趋化因子受体活性的氨基环戊基杂环和碳环调节剂
|
KR101128065B1
(ko)
|
2004-05-26 |
2012-04-12 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
신나미드 화합물
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
RU2376309C2
(ru)
|
2004-07-01 |
2009-12-20 |
Асубио Фарма Ко., Лтд. |
Производное тиенопиразола, имеющее ингибирующую фосфодиэстеразу 7 (pde 7) активность
|
US7276631B2
(en)
*
|
2004-07-20 |
2007-10-02 |
Bristol-Myers Squibb Company |
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
|
JO2629B1
(en)
|
2004-08-19 |
2012-06-24 |
افينتيس فارما سوتيكالز انك |
Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
|
US7411093B2
(en)
*
|
2004-12-20 |
2008-08-12 |
Hoffman-La Roche Inc. |
Aminocycloalkanes as DPP-IV inhibitors
|
US20090069384A1
(en)
|
2005-01-19 |
2009-03-12 |
Biolipox Ab |
Thienopyrroles useful in the treatment of inflammation
|
CN100391945C
(zh)
|
2005-05-31 |
2008-06-04 |
浙江大学 |
一种s-(-)-吲哚啉-2-羧酸的合成方法
|
US20090306169A1
(en)
|
2005-10-06 |
2009-12-10 |
Brandish Philip E |
Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors
|
UA95788C2
(en)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Fused pyrrole derivatives
|
NZ569630A
(en)
|
2006-01-06 |
2011-09-30 |
Sepracor Inc |
Cycloalkylamines as monoamine reuptake inhibitors
|
ES2566479T3
(es)
|
2006-01-06 |
2016-04-13 |
Sunovion Pharmaceuticals Inc. |
Inhibidores de reabsorción de monoamina con base en tetralona
|
DK2013835T3
(en)
|
2006-03-31 |
2015-12-14 |
Sunovion Pharmaceuticals Inc |
Preparation of chiral amides and AMINES
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
US20080058395A1
(en)
|
2006-06-30 |
2008-03-06 |
Sepracor Inc. |
Fused heterocyclic inhibitors of D-amino acid oxidase
|
US7579370B2
(en)
|
2006-06-30 |
2009-08-25 |
Sepracor Inc. |
Fused heterocycles
|
KR20090024823A
(ko)
|
2006-06-30 |
2009-03-09 |
세프라코 아이엔시. |
D-아미노산 옥시다제의 융합된 헤테로사이클 억제제
|
CN1962656A
(zh)
|
2006-11-29 |
2007-05-16 |
沈阳药科大学 |
吲哚美辛5-氟尿嘧啶甲酯药用化合物及其制剂和制备方法
|
UY30829A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Abbott Lab |
Compuestos agonistas y antagonistas del receptor de esfinfosina-1-fosfato
|
US20090099248A1
(en)
|
2007-01-18 |
2009-04-16 |
Sepracor Inc. |
Inhibitors of d-amino acid oxidase
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
WO2008151156A1
(en)
*
|
2007-05-31 |
2008-12-11 |
Sepracor Inc. |
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
|
WO2010017418A1
(en)
|
2008-08-07 |
2010-02-11 |
Sepracor Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|